Latest News

Topiramate reduces heavy drinking among patients seeking to cut down on alcohol consumption

Heavy alcohol consumption is common in the United States and takes a personal and societal toll, with an annual estimated cost of 3.5 billion. Researchers have shown that the anticonvulsant medication, topiramate, previously shown to reduce drinking in patients committed to abstinence from alcohol, can also be helpful in treating problem drinkers whose aim is to curb their alcohol consumption ? particularly among a specific group of patients whose genetic makeup appears to be linked to the efficacy of the therapy.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Neuroscientists identify new way several brain areas communicate

  • Air pollution linked to slower cognitive development in children

  • Creative genius driven by distraction

  • Republicans trust science -- except when it comes to health insurance and gay adoption

  • Alcohol screening, intervention for risky drinking: A guide for physicians

  • Anxious people more apt to make bad decisions amid uncertainty

  • Myelin-maker: How an FDA-approved drug boosts myelin synthesis

  • Vaccine skeptics aren't swayed by emotional scare tactics

  • Administering Sedatives for Patients Receiving General Anesthesia Questioned

  • Examination of prior authorization policies for antipsychotic prescribing to children

  •